During the past decade, Advocate Medical Group Midwest Heart Specialists conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Advocate Medical Group Midwest Heart Specialists" are "Hyperlipidemia" (1 trials) and "Hypertriglyceridemia" (1 trials). Many other conditions were trialed in "Advocate Medical Group Midwest Heart Specialists" in a lesser frequency.

Most popular intervention types in "Advocate Medical Group Midwest Heart Specialists" are "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atorvastatin" (1 trials), "Bococizumab (PF-04950615;RN316)" (1 trials), "Placebo" (1 trials), "Placebo for Bococizumab (PF-04950615;RN316)" (1 trials) and "Placebo for atorvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advocate Medical Group Midwest Heart Specialists" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Advocate Medical Group Midwest Heart Specialists". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Advocate Medical Group Midwest Heart Specialists, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Advocate Medical Group Midwest Heart Specialists, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".